KIAA1755

Model summary

A large human signaling scaffold that assembles and activates small GTPase pathways. Its N-terminal exchange-factor module and distal anchoring region cooperate to catalyze nucleotide exchange on Rho-family switches and to organize effector-rich assemblies. Operating primarily in the soluble phase but dynamically associating with membrane-proximal complexes, it tunes cytoskeletal and membrane-associated signaling by coordinating guanine nucleotide exchange and multivalent protein interactions.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is bracketed by IPR060650 (Rho guanine nucleotide exchange factor 40-like, N-terminal domain, residues 5–182) and IPR060651 (Rho guanine nucleotide exchange factor 40-like, C-terminal domain, residues 996–1052), both embedded within a long IPR052231 signature (Rho guanine nucleotide exchange factor 40-related family, residues 1–1097) that spans essentially the full length. This bipartite N- and C-terminal arrangement is characteristic of large RhoGEF scaffolds that use an N-terminal targeting/assembly module and a distal regulatory/anchoring module to organize signaling surfaces. Such architectures typically create multivalent interfaces that stabilize small GTPase modules and their effectors, causally supporting GO:0005515 protein binding as a core capability. The presence of a RhoGEF-like fold that catalyzes nucleotide exchange on Rho-family GTPases establishes GO:0005085 guanyl-nucleotide exchange factor activity as the catalytic centerpiece.

2. 02

   Catalyzing GDP release and GTP loading on Rho-family GTPases positions this protein squarely within GO:0051056 regulation of small GTPase mediated signal transduction.

   The N-terminal RhoGEF-like domain (IPR060650) provides the catalytic platform for exchange, while the extended family scaffold (IPR052231) and the C-terminal RhoGEF-like domain (IPR060651) coordinate assembly and spatial control. This modular design causes the protein to tune cytoskeletal and membrane-proximal pathways by gating the activation cycles of small GTPases.

3. 03

   Cellular placement follows from the same architecture.

   Large RhoGEF scaffolds operate in the soluble phase but are recruited to membrane-associated complexes through their terminal modules; this explains a dual soluble–peripheral distribution. Accordingly, I infer residence in the GO:0005829 cytosol with regulated association to the GO:0005886 plasma membrane, where membrane-proximal GTPase signaling is initiated.

4. 04

   Mechanistically, the N-terminal RhoGEF-like domain nucleates assembly and exchange on Rho-family nodes, while the C-terminal module anchors the complex and modulates access to substrates and effectors.

   This arrangement predicts interactions with Rho-family GTPases and their effectors at membrane–cytoskeleton interfaces. I hypothesize transient complexes with RhoA/Rac1/Cdc42 modules and their downstream effectors (e.g., WASP/WAVE and formin assemblies), as well as adaptor systems that couple to the plasma membrane. These assemblies would allow the protein to sense and relay signals from membrane cues to cytoskeletal remodeling and small GTPase pathway control.